Items where authors include "de Witte, Theo"

Export as [feed] Atom [feed] RSS
Number of items: 13.

Article

Efficace, Fabio, Koinig, Karin, Cottone, Francesco et al. (14 more authors) (2022) Raising the standards of patient-centered outcomes research in myelodysplastic syndromes : Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project. Cancer Medicine. ISSN 2045-7634

Garelius, H K G, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Bagguley, Timothy Charles orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2022) Erythropoietin stimulation agents significantly improves outcome in lower risk MDS. HemaSphere. S168. pp. 69-70. ISSN 2572-9241

Wouters, Hanneke J C M, Conrads-Frank, Annette, Koinig, Karin A et al. (8 more authors) (2021) The anemia-independent impact of myelodysplastic syndromes on health-related quality of life. Annals of Hematology. pp. 2921-2932. ISSN 1432-0584

Oster, Howard S., Crouch, Simon orcid.org/0000-0002-3026-2859, Smith, Alexandra orcid.org/0000-0002-1111-966X et al. (26 more authors) (2021) A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS. Blood Advances. pp. 3066-3075. ISSN 2473-9537

Hoeks, Marlijn, Bagguley, Tim orcid.org/0000-0002-6150-3467, van Marrewijk, Corine et al. (23 more authors) (2021) Toxic iron species in lower-risk myelodysplastic syndrome patients : course of disease and effects on outcome. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. pp. 1745-1750. ISSN 1476-5551

de Witte, Theo, Malcovati, Luca, Fenaux, Pierre et al. (26 more authors) (2020) Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective. Haematologica. pp. 2516-2523.

Itzykson, Raphael, Crouch, Simon orcid.org/0000-0002-3026-2859, Travaglino, Erica et al. (24 more authors) (2018) Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes. Blood Advances. pp. 2079-2089. ISSN 2473-9537

Stahl, Maximilian, DeVeaux, Michelle, de Witte, Theo et al. (24 more authors) (2018) The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort. Blood Advances. pp. 1765-1772. ISSN 2473-9537

Stauder, Reinhard, Yu, Ge orcid.org/0000-0002-0891-2501, Koinig, Karin A. et al. (22 more authors) (2018) Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. ISSN 1476-5551

de Swart, Louise, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Haase, Detlef et al. (26 more authors) (2018) Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS. Leukemia research. pp. 21-26. ISSN 0145-2126

de Swart, Louise, Reiniers, ChloƩ, Bagguley, Timothy orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2017) Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes. Haematologica-The hematology journal. pp. 1-37. ISSN 0390-6078

de Swart, Louise, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Mackenzie, Marius et al. (21 more authors) (2017) Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. Annals of Hematology. ISSN 1432-0584

Book Section

Varghese, Julian, Holz, Christian, Neuhaus, Phillip et al. (14 more authors) (2017) Key Data Elements in Myeloid Leukemia. In: Exploring Complexity in Health: An Interdisciplinary Systems Approach. Studies in Health Technology and Informatics . IOS Press , pp. 282-286.

This list was generated on Mon Apr 22 02:28:56 2024 BST.